Patrick Heron
InvestorManaging Partner at Frazier Life Sciences · Managing Partner at Frazier Healthcare Partners
Palo Alto
FoundedArcutis BiotherapeuticsCidara TherapeuticsCollegium PharmaceuticalImago BioSciences, Inc.Iterum TherapeuticsNexcida Therapeutics
About
Patrick Heron co-leads Frazier's Life Sciences team and is a Managing Partner and co-founder of that team, having joined the firm in 1999 and opened its Palo Alto office in 2003. He invests across therapeutics, from early-stage drug development to commercial-stage pharmaceutical companies. Before Frazier, he helped build McKinsey & Company's West Coast biotechnology consulting practice, and he holds an M.B.A. from Harvard Business School and a B.A. from the University of North Carolina at Chapel Hill.
Invests in
Biotech
Experience
- Frazier Life SciencesManaging Partnercurrent1999 — presentPalo Alto, California, United States
- Alpha-9 OncologyBoard Chaircurrent2022 — presentBoston, Massachusetts, United States
- Mirum PharmaceuticalsBoard Membercurrent2018 — presentSan Francisco Bay Area
- Alceptor TherapeuticsBoard Membercurrent2020 — present
- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)Board Membercurrent2016 — present
- MBX Biosciences, Inc.Board Membercurrent2020 — presentIndianapolis, Indiana, United States
- BlueWater Biosciences, IncBoard Membercurrent2024 — present
- Aspen Neuroscience, Inc.Board Observercurrent2020 — presentSan Diego, California, United States
- Gates FoundationInvestment Committee Member - Strategic Investment Fundcurrent2020 — presentSeattle, Washington, United States
- Tubulis GmbHBoard Member2025 — 2026Munich, Bavaria, Germany
- HilleVaxBoard Member2021 — 2025Boston, Massachusetts, United States
- SanReno TherapeuticsBoard Member2022 — 2023Shanghai, China
- Scout BioChairman of the Board2018 — 2023Greater Philadelphia
- IMAGO BIOSCIENCES LTDBoard Member2014 — 2022San Francisco Bay Area
- VaxcyteBoard Member2017 — 2021Redwood City
- Passage BioBoard Member2018 — 2021Greater Philadelphia
- Iterum Therapeutics LimitedBoard Member2015 — 2021Dublin, Ireland
- AmunixBoard Member2019 — 2021San Francisco Bay Area
- Zavante Therapeutics, Inc.Board Member2016 — 2018San Diego, California
- Silvergate PharmaceuticalsBoard Member2011 — 2018Denver, CO
Education
- Harvard Business SchoolMBA1994 — 1996
- The University of North Carolina at Chapel HillBA, Political Science1988 — 1992
Skills & more
+8 more
HealthcareInvestor RelationsEntrepreneurshipFinancial ModelingGrowth CapitalAngel InvestingLife SciencesStrategyFrom Patrick's professional profile.
Same school
Also attended Harvard Business School2,000
+ 1,994 more
Also attended The University of North Carolina at Chapel Hill200
+ 194 more
Shared employers
Also worked at Tubulis GmbH5
Also worked at Scout Bio5
Also worked at Passage Bio1
Also worked at McKinsey & Company1,444
+ 1,438 more
Deals · 19
MBX BiosciencesBoard seat
via Frazier Life Sciences · filed Nov 2022 · $115.2M raise
SutroVaxBoard seat
via Frazier Life Sciences · filed Apr 2020 · $110M raise
Iterum Therapeutics BermudaBoard seat
via Frazier Life Sciences · filed Jan 2020 · $51.6M raise
Arcutis BiotherapeuticsBoard seat
via Frazier Life Sciences · filed Oct 2019 · $94.5M raise
Passage BioBoard seat
via Frazier Life Sciences · filed Sep 2019 · $110M raise
Mirum PharmaceuticalsBoard seat
via Frazier Life Sciences · filed Nov 2018 · $120.1M raise
Recida TherapeuticsBoard seat
via Frazier Life Sciences · filed Jul 2018 · $10.7M raise
Imago BioSciences, Inc.Board seat
via Frazier Life Sciences · filed Feb 2017 · $40.5M raise
SG PharmaceuticalsBoard seat
via Frazier Life Sciences · filed Apr 2016 · $45.7M raise
Silvergate PharmaceuticalsBoard seat
via Frazier Life Sciences · filed Oct 2015 · $4.6M raise
Nexcida TherapeuticsBoard seat
via Frazier Life Sciences · filed Jun 2015 · $21.3M raise
Collegium PharmaceuticalBoard seat
via Frazier Life Sciences · filed Mar 2015 · $50M raise
Cidara TherapeuticsBoard seat
via Frazier Life Sciences · filed Feb 2015 · $42M raise
IgnytaLed round
via Frazier Life Sciences · filed Nov 2015
CalixaLed round
CerexaLed round
CollegiumLed round
MarcadiaLed round
PreCision DermatologyLed round
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Frazier Life Sciences
Network1
Investors connected to Patrick in public investor directories — a warm-intro map.












)
















